Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Crooke

Showing results (31-40 of 311) with videos related to

Pageof 32
Sort By:
Current Opinion in Biotechnology|December 1, 1992
Oligonucleotide therapyS T Crooke
Antisense Research and Development|January 1, 1994
Progress in evaluation of the potential of antisense technologyS T Crooke
Biochemical Pharmacology|September 15, 1985
Studies on the fluorescence labeling of human red blood cell membrane ghosts with 4'-(9-acridinylamino)methanesulfon-m-anisidideA Wong, S T Crooke
Molecular Pharmacology|November 1, 1995
Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotidesD Hodges, S T Crooke
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Depletion of protein kinase C-alpha by antisense oligonucleotides alters beta-adrenergic function and reverses the phorbol ester-induced reduction of isoproterenol-induced adenosine 3'-5'-cyclic monophosphate accumulation in murine Swiss 3T3 fibroblastsL Levesque, S T Crooke
Methods in Enzymology|October 5, 2001
Preparation and use of ZFY-6 zinc finger ribonucleaseW F Lima, S T Crooke
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
The cellular and molecular pharmacology of auranofin and related gold complexesS T Crooke, R M Snyder
Biochemistry|January 14, 1997
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybridsW F Lima, S T Crooke
Annual Review of Pharmacology and Toxicology|January 1, 1996
Progress in antisense oligonucleotide therapeuticsS T Crooke, C F Bennett
Cancer Treatment Reviews|June 1, 1979
Etoposide (VP-16-213)B F Issell, S T Crooke
Pageof 32

Showing results (31-40 of 311) with videos related to

Sort By:
Pageof 32
Current Opinion in Biotechnology|December 1, 1992
Oligonucleotide therapyS T Crooke
Antisense Research and Development|January 1, 1994
Progress in evaluation of the potential of antisense technologyS T Crooke
Biochemical Pharmacology|September 15, 1985
Studies on the fluorescence labeling of human red blood cell membrane ghosts with 4'-(9-acridinylamino)methanesulfon-m-anisidideA Wong, S T Crooke
Molecular Pharmacology|November 1, 1995
Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotidesD Hodges, S T Crooke
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Depletion of protein kinase C-alpha by antisense oligonucleotides alters beta-adrenergic function and reverses the phorbol ester-induced reduction of isoproterenol-induced adenosine 3'-5'-cyclic monophosphate accumulation in murine Swiss 3T3 fibroblastsL Levesque, S T Crooke
Methods in Enzymology|October 5, 2001
Preparation and use of ZFY-6 zinc finger ribonucleaseW F Lima, S T Crooke
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
The cellular and molecular pharmacology of auranofin and related gold complexesS T Crooke, R M Snyder
Biochemistry|January 14, 1997
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybridsW F Lima, S T Crooke
Annual Review of Pharmacology and Toxicology|January 1, 1996
Progress in antisense oligonucleotide therapeuticsS T Crooke, C F Bennett
Cancer Treatment Reviews|June 1, 1979
Etoposide (VP-16-213)B F Issell, S T Crooke
Pageof 32